SCHEMBL339469

SCHEMBL339469

Cc1cc(=O)c(OCc2ccccc2)c(C(=O)NC2CC2)n1C1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CNR2 P34972 3/20 0.44
CNR1 P21554 2/20 0.44
SGMS2 Q8NHU3 1/20 0.43
BRD4 O60885 5/20 0.43
MAOB P27338 1/20 0.40
RIPK2 O43353 1/20 0.40
GAA P10253 1/20 0.39
TRIM24 O15164 1/20 0.39
BRD1 O95696 1/20 0.39
CCL2 P13500 1/20 0.39
TAF1 P21675 1/20 0.39
BRD2 P25440 1/20 0.39
SMARCA2 P51531 1/20 0.39
SMARCA4 P51532 1/20 0.39
BRPF1 P55201 1/20 0.39
EP300 Q09472 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338508 0.95 SGMS2 (0.51) MEN1KMT2AALDH1A1CNR2CNR1
SCHEMBL338440 0.89 SMN1; SMN2 (0.42) MEN1KMT2AALDH1A1BRD4GAA
SCHEMBL338492 0.88 NOTUM (0.42) MEN1KMT2AALDH1A1GAA
SCHEMBL338839 0.87 RIPK1 (0.46) RIPK1MEN1KMT2AALDH1A1CNR2
SCHEMBL339330 0.86 MEN1 (0.43) MEN1KMT2AALDH1A1BRD4
SCHEMBL338604 0.84 NAAA (0.41) MEN1KMT2AALDH1A1CNR2CNR1
SCHEMBL338494 0.83 KMT2A (0.52) RIPK1MEN1KMT2AALDH1A1CNR2
SCHEMBL338594 0.83 MEN1 (0.49) RIPK1MEN1KMT2AALDH1A1CNR2
SCHEMBL339206 0.83 RIPK1 (0.46) RIPK1KMT2AALDH1A1SGMS2BRD4
SCHEMBL339628 0.83 BRD4 (0.38) MEN1KMT2AALDH1A1BRD4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687298-B1 CYCLOALKYL DERIVATIVES OF 3-HYDROXY-4-PYRIDINONES APOTEX INC (CA) 2012-12-26 EP disclosed
US-8097624-B2 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones APOTEX INC. (CA) 2012-01-17 US disclosed
US-20090170850-A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones APOTEX INC. 2009-07-02 US disclosed
US-7410985-B2 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones APOTEX INC. (CA) 2008-08-12 US disclosed
EP-1687298-A4 CYCLOALKYL DERIVATIVES OF 3-HYDROXY-4-PYRIDINONES APOTEX INC (CA) 2007-10-17 EP disclosed
US-20070082904-A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention APOTEX INC. (CA) 2007-04-12 US disclosed
EP-1687298-A1 CYCLOALKYL DERIVATIVES OF 3-HYDROXY-4-PYRIDINONES Apotex Inc. (CA) 2006-08-09 EP disclosed
WO-2005049609-A1 CYCLOALKYL DERIVATIVES OF 3-HYDROXY-4-PYRIDINONES APOTEX INC. (CA) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170850-A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones HAMP, C1S, C1R RIPK1 4240/4885MEN1 883/4885KMT2A 3229/4885
US-20070082904-A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention HAMP, C1S, SLC40A1 RIPK1 3711/4885MEN1 640/4885KMT2A 4366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.